This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
bacteria:t3e:xopl [2020/07/03 17:48] rkoebnik |
bacteria:t3e:xopl [2022/07/13 18:14] (current) rkoebnik [Biological function] |
||
---|---|---|---|
Line 7: | Line 7: | ||
Class: XopL\\ | Class: XopL\\ | ||
Family: XopL\\ | Family: XopL\\ | ||
- | Prototype: | + | Prototype: |
RefSeq ID: [[https:// | RefSeq ID: [[https:// | ||
- | Examples of other sequences: XopL< | + | Examples of other sequences: XopL< |
- | 3D structure: Full-length XopL< | + | 3D structure: |
===== Biological function ===== | ===== Biological function ===== | ||
Line 30: | Line 31: | ||
=== Phenotypes === | === Phenotypes === | ||
- | * The T3Es XopL< | + | * XopL< |
- | * In contrast, XopL< | + | * In contrast, XopL< |
+ | * XopL< | ||
* XopL< | * XopL< | ||
* Transient expression of XopL, led to a nearly complete elimination of stromules and the relocation of plastids to the nucleus and further characterization of XopL revealed that the E3 ligase activity is essential for two plastid phenotypes (Erickson //et al//., 2016). | * Transient expression of XopL, led to a nearly complete elimination of stromules and the relocation of plastids to the nucleus and further characterization of XopL revealed that the E3 ligase activity is essential for two plastid phenotypes (Erickson //et al//., 2016). | ||
* XopL< | * XopL< | ||
* XopL< | * XopL< | ||
+ | * // | ||
=== Localization === | === Localization === | ||
Line 43: | Line 45: | ||
=== Enzymatic function === | === Enzymatic function === | ||
- | E3 ubiquitin ligase activity. | + | E3 ubiquitin ligase activity |
=== Interaction partners === | === Interaction partners === | ||
- | Unknown. | + | XopL< |
===== Conservation ===== | ===== Conservation ===== | ||
Line 53: | Line 55: | ||
=== In xanthomonads === | === In xanthomonads === | ||
- | Yes in // | + | Yes (//e.g.//, //X. euvesicatoria//, |
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Line 61: | Line 62: | ||
===== References ===== | ===== References ===== | ||
- | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // | + | Adlung N (2016). Charakterisierung der Avirulenzaktivität von XopQ und Identifizierung möglicher Interaktoren von XopL aus // |
+ | |||
+ | Erickson JL, Adlung N, Lampe C, Bonas U, Schattat MH (2018). The // | ||
+ | |||
+ | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | ||
- | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector | + | Leong JX, Raffeiner M, Spinti D, Langin G, Franz-Wachtel M, Guzman AR, Kim JG, Pandey P, Minina AE, Macek B, Hafrén A, Bozkurt TO, Mudgett MB, Börnke F, Hofius D, Üstün S (2022). A bacterial |
- | Liu Y, Long J, Shen D, Song C (2016). // | + | Liu Y, Long J, Shen D, Song C (2016). // |
- | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // | + | Popov G, Fraiture M, Brunner F, Sessa G (2016). Multiple // |
Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | Singer AU, Schulze S, Skarina T, Xu X, Cui H, Eschen-Lippold L, Egler M, Srikumar T, Raught B, Lee J, Scheel D, Savchenko A, Bonas U (2013). A pathogen type III effector with a novel E3 ubiquitin ligase architecture. PLoS Pathog. 9: e1003121. DOI: [[https:// | ||
- | Soni M, Mondal KK. (2017). // | + | Soni M, Mondal KK. (2017). // |
- | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< | + | Yan X, Tao J, Luo HL, Tan LT, Rong W, Li HP, He CZ (2019). A type III effector XopL< |